Invitrogen™ Human EVER2 Synthetic Peptide
EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.
- Gene ID (Enter)
- 147138
- Species
- Human
- Purification method
- Purified
- Accession number
- Q8IU68
- Common name
- Human EVER2
- Brand
- Invitrogen
EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.
EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.
Epidermodysplasia verruciformis (EV) is an autosomal recessive genodermatosis associated with a high risk of skin cancers resulting from a high susceptibility to infection by specific human papillomaviruses. Mutations in two homologous genes EVER1 and EVER2 cause the majority of EV cases. These two proteins form a complex and interact with the zinc transporter ZnT-1 in the endoplasmic reticulum. Cells lacking EVER2 accumulated higher levels of zinc in the nucleolus and nucleus compare to those cells with and intact EVER2 gene, indicating that one role of EVER2 is to regulate the intracellular distribution of zinc.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15318840 |
| Specifications | |
| Gene ID (Enter) | 147138 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q8IU68 |
| Common name | Human EVER2 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | TMC8 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-0646 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |